Osaic Holdings
TRAW icon

Osaic Holdings’s Traws Pharma TRAW Stock Holding History

Osaic Holdings’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$9 – 8097
2025
Q4 		$9 Buy
+8
New +$18 ﹤0.01% 7765
2024
Q3 		– Sell
-12
Closed -$137 – 7573
2024
Q2 		$137 Buy
+12
New +$193 ﹤0.01% 7208
2024
Q1 		– Hold
0
– – – 7145
2023
Q4 		– Sell
-40
Closed -$681 – 7264
2023
Q3 		$714 Hold
40
– – ﹤0.01% 6918
2023
Q2 		$1.19K Hold
40
– – ﹤0.01% 6834
2023
Q1 		$734 Buy
+40
New +$865 ﹤0.01% 7051
2022
Q4 		– Hold
0
– – – 7465
2022
Q3 		– Hold
0
– – – 7553
2022
Q2 		– Hold
0
– – – 7644
2022
Q1 		– Hold
0
– – – 7549
2021
Q4 		– Hold
0
– – – 7613
2021
Q3 		– Hold
0
– – – 7343
2021
Q2 		– Hold
0
– – – 7154
2021
Q1 		– Hold
0
– – – 6971
2020
Q4 		– Hold
0
– – – 6608
2020
Q3 		– Hold
0
– – – 6442
2020
Q2 		– Hold
0
– – – 6369
2020
Q1 		– Hold
0
– – – 6206

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings's TRAW Position: Q1 2026 in Review

Osaic Holdings sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 8 shares — an estimated $9 sold.

Osaic Holdings first reported a position in TRAW in Q1 2023 and held it in 5 quarters. The position peaked at $1.19K in Q2 2023. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Osaic Holdings reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 8 Traws Pharma shares in Q1 2026, an estimated $9.
  • Osaic Holdings first reported a position in Traws Pharma in Q1 2023 and held it in 5 quarters.
  • Osaic Holdings's Traws Pharma position peaked at $1.19K in Q2 2023.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.